National and Kapodistrian University of Athens
Επίπεδα λιποκινών σε ασθενείς με χρόνια ηπατίτιδα
Abstract
dc:descriptionAdipokines are recently discovered adipose tissue hormones with systemic effects. Leptin and adiponectin have been implicated in the pathogenesis and progression of non-alcoholic fatty liver disease and chronic hepatitis C, while little is known about the role of resistin in chronic liver diseases. The potential role of adipokines on patients with chronic hepatitis B is inadequately studied. In the present study, we investigated the above three serum adipokines levels in relation to the etiology of liver disease and determined their associations with various anthropometrical, epidemiological, metabolic host factors as well as with histological severity. We prospectively evaluated 146 patients who consecutively underwent liver biopsy. Of those 146 patients, 52 had HBeAg-negative chronic hepatitis B (CHB), 70 had chronic hepatitis C (CHC) and 24 non-alcoholic steatohepatitis (NASH). Detailed epidemiological, anthropometrical and laboratory data were recorded and insulin resistance was calculated using the HOMA index. All serum adipokines levels were determined in stored serum samples using immunoenzymometric assays. Serum samples were obtained after an overnight fasting on the liver biopsy day and were stored in aliquots at -200C until assayed. Histological lesions were evaluated blindly according to Ishak’s and Brunt’s classification for CHB/CHC and NASH, respectively. Serum adipokine levels were similar between CHB and CHC, while CHB/CHC compared to NASH patients had significantly lower leptin (8.3±7.3 vs. 17.6±16.6 ng/mL, P=0.012) and higher adiponectin (10.2±5.1 vs. 7.5±4 µg/mL, P=0.018) and resistin levels (7.1±2.5 vs. 5.7±2.8 ng/mL, P=0.016). In CHB/CHC, there was no significant association between steatosis or necroinflammation and adipokines levels, while presence of moderate/severe fibrosis (stage 4-6) was associated with higher leptin and adiponectin levels in male but not in female patients. Serum leptin and resistin levels were associated with severe fibrosis in NASH patients; however due to the small sample size this finding could not be verified in multivariate analysis. Lower resistin levels were independently associated with moderate/severe fibrosis in chronic viral hepatitis irrespective of gender or other factors (adjusted odds ratio=0.788, P=0.035). In conclusion, serum adipokines levels depended on the etiology of liver disease and differed between chronic viral hepatitis and NASH, but not between CHB and CHC. In CHB/CHC, resistin levels are independently associated with fibrosis severity, while it seems to be a gender effect in the association of leptin and adiponectin levels with fibrosis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsochatzis, Emmanouil
- Τσόχατζης, Εμμανουήλ
Subjects
dc:subject × 20- Λιποκίνες
- Λεπτίνη
- Αδιπονεκτίνη
- Ρεζιστίνη
- Χρόνια ηπατίτιδα Β
- Χρόνια ηπατίτιδα C
- Μη αλκοολική στεατοηπατίτιδα
- Αντίσταση στην ινσουλίνη
- Adipokines
- Leptin
- Adiponectin
- Resistin
- Chronic hepatitis B
- Chronic hepatitis C
- Non-alcoholic steatohepatitis
- Insulin resistance
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22971